Skip to main content
Erschienen in: Current Gastroenterology Reports 9/2016

01.09.2016 | Esophagus (JO Clarke and NK Ahuja, Section Editors)

Endoscopic Options for Gastroesophageal Reflux: Where Are We Now and What Does the Future Hold?

verfasst von: George Triadafilopoulos

Erschienen in: Current Gastroenterology Reports | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Early in the twenty-first century, novel endoscopic techniques were introduced for the management of gastroesophageal reflux disease, providing minimally invasive ways to eliminate pharmacologic acid inhibition and avoid the need for anti-reflux surgery. These techniques do not significantly alter the anatomy of the gastroesophageal junction, minimizing short- and long-term adverse effects, such as dysphagia and bloating. After extensive clinical testing, many endoscopic therapies were abandoned due to either lack of durable efficacy or unfavorable safety profile. Today, only four such therapies remain clinically available, each with variable levels of clinical validation and market penetration. This review will provide an assessment of these endoscopic therapies, highlighting their respective strengths and weaknesses and their present and future applicability to patients with gastroesophageal reflux disease.
Literatur
1.
Zurück zum Zitat Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf). 2015;3(1):41–53.CrossRef Subramanian CR, Triadafilopoulos G. Refractory gastroesophageal reflux disease. Gastroenterol Rep (Oxf). 2015;3(1):41–53.CrossRef
2.
Zurück zum Zitat Kamolz T, Pointner R. Expectations of patients with gastroesophageal reflux disease for the outcome of laparoscopic antireflux surgery. Surg Laparosc Endosc Percutan Tech. 2002;12(6):389–92.CrossRefPubMed Kamolz T, Pointner R. Expectations of patients with gastroesophageal reflux disease for the outcome of laparoscopic antireflux surgery. Surg Laparosc Endosc Percutan Tech. 2002;12(6):389–92.CrossRefPubMed
3.••
Zurück zum Zitat Reimer C. Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol. 2013;27(3):443–54. Review of safety of PPIs that highlights concerns about long-term pharmacologic therapy of GERD.CrossRefPubMed Reimer C. Safety of long-term PPI therapy. Best Pract Res Clin Gastroenterol. 2013;27(3):443–54. Review of safety of PPIs that highlights concerns about long-term pharmacologic therapy of GERD.CrossRefPubMed
4.
Zurück zum Zitat Hirano I, Richter JE. Practice Parameters Committee of American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–85.CrossRefPubMed Hirano I, Richter JE. Practice Parameters Committee of American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–85.CrossRefPubMed
5.
Zurück zum Zitat Yuan Y, Hunt RH. Evolving issues in the management of reflux disease? Curr Opin Gastroenterol. 2009;25(4):342–51.CrossRefPubMed Yuan Y, Hunt RH. Evolving issues in the management of reflux disease? Curr Opin Gastroenterol. 2009;25(4):342–51.CrossRefPubMed
6.
Zurück zum Zitat Frazzoni M, Manno M, De Micheli E, Savarino V. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors. Dig Liver Dis. 2007;39(5):415–21.CrossRefPubMed Frazzoni M, Manno M, De Micheli E, Savarino V. Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors. Dig Liver Dis. 2007;39(5):415–21.CrossRefPubMed
7.•
Zurück zum Zitat Lin D. Triadafilopoulos G. Dual ambulatory ph monitoring in patients with gastroesophageal reflux rendered asymptomatic with proton pump inhibitor therapy. Dig Dis Sci. 2015;60(5):1343–9. Cohort study that highlights the incomplete control of esophageal acid exposure with PPIs.CrossRefPubMed Lin D. Triadafilopoulos G. Dual ambulatory ph monitoring in patients with gastroesophageal reflux rendered asymptomatic with proton pump inhibitor therapy. Dig Dis Sci. 2015;60(5):1343–9. Cohort study that highlights the incomplete control of esophageal acid exposure with PPIs.CrossRefPubMed
8.
Zurück zum Zitat Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Dis Esophagus. 2013;26(5):443–50.CrossRefPubMed Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Dis Esophagus. 2013;26(5):443–50.CrossRefPubMed
9.
Zurück zum Zitat Frazzoni M, Piccoli M, Conigliaro R, Frazzoni L, Melotti G. Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol. 2014;20(39):14272–9.CrossRefPubMedPubMedCentral Frazzoni M, Piccoli M, Conigliaro R, Frazzoni L, Melotti G. Laparoscopic fundoplication for gastroesophageal reflux disease. World J Gastroenterol. 2014;20(39):14272–9.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Roman S, Lin Z, Kwiatek MA, et al. Weak peristalsis in esophageal pressure topography: classification and association with dysphagia. Am J Gastroenterol. 2011;106:349–56.CrossRefPubMed Roman S, Lin Z, Kwiatek MA, et al. Weak peristalsis in esophageal pressure topography: classification and association with dysphagia. Am J Gastroenterol. 2011;106:349–56.CrossRefPubMed
11.
Zurück zum Zitat Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–17.CrossRefPubMed Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27:160–17.CrossRefPubMed
12.••
Zurück zum Zitat Gyawali CP, Bredenoord AJ, Conklin JL, et al. Evaluation of esophageal motor function in clinical practice. Neurogastroenterol Motil. 2013;25:99–133. Authoritative review of an increasingly recognized entity.CrossRefPubMed Gyawali CP, Bredenoord AJ, Conklin JL, et al. Evaluation of esophageal motor function in clinical practice. Neurogastroenterol Motil. 2013;25:99–133. Authoritative review of an increasingly recognized entity.CrossRefPubMed
13.
Zurück zum Zitat Kohn GP, Price RR, DeMeester SR, Zehetner J, Muensterer OJ, Awad Z, et al. Guidelines for the management of hiatal hernia. Surg Endosc. 2013;27(12):4409–28.CrossRefPubMed Kohn GP, Price RR, DeMeester SR, Zehetner J, Muensterer OJ, Awad Z, et al. Guidelines for the management of hiatal hernia. Surg Endosc. 2013;27(12):4409–28.CrossRefPubMed
14.
Zurück zum Zitat Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.CrossRefPubMed Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.CrossRefPubMed
15.
Zurück zum Zitat Kindel TL, Oleynikov D. The Improvement of gastroesophageal reflux disease and Barrett’s after bariatric surgery. Obes Surg. 2016. Kindel TL, Oleynikov D. The Improvement of gastroesophageal reflux disease and Barrett’s after bariatric surgery. Obes Surg. 2016.
16.
Zurück zum Zitat Mattar SG, Qureshi F, Taylor D, Schauer PR. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc. 2006;20(6):850–4.CrossRefPubMed Mattar SG, Qureshi F, Taylor D, Schauer PR. Treatment of refractory gastroesophageal reflux disease with radiofrequency energy (Stretta) in patients after Roux-en-Y gastric bypass. Surg Endosc. 2006;20(6):850–4.CrossRefPubMed
17.
Zurück zum Zitat Liang WT, Wang ZG, Wang F, Yang Y, Hu ZW, Liu JJ, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study. BMC Gastroenterol. 2014;14:178. doi:10.1186/1471-230X-14-178.CrossRefPubMedPubMedCentral Liang WT, Wang ZG, Wang F, Yang Y, Hu ZW, Liu JJ, et al. Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study. BMC Gastroenterol. 2014;14:178. doi:10.​1186/​1471-230X-14-178.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Liang WT, Wu JM, Wang F, Hu ZW, Wang ZG. Stretta radiofrequency for gastroesophageal reflux disease-related respiratory symptoms: a prospective 5-year study. Minerva Chir. 2014;69(5):293–9.PubMed Liang WT, Wu JM, Wang F, Hu ZW, Wang ZG. Stretta radiofrequency for gastroesophageal reflux disease-related respiratory symptoms: a prospective 5-year study. Minerva Chir. 2014;69(5):293–9.PubMed
20.
Zurück zum Zitat Liang WT, Wu JN, Wang F, Hu ZW, Wang ZG, Ji T, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease. Minerva Chir. 2014;69(4):217–23.PubMed Liang WT, Wu JN, Wang F, Hu ZW, Wang ZG, Ji T, et al. Five-year follow-up of a prospective study comparing laparoscopic Nissen fundoplication with Stretta radiofrequency for gastroesophageal reflux disease. Minerva Chir. 2014;69(4):217–23.PubMed
21.
Zurück zum Zitat Liang WT, Wu JM, Hu ZW, Wang ZG, Zhu GC, Zhang C. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency. Minerva Chir. 2014;69(3):121–7.PubMed Liang WT, Wu JM, Hu ZW, Wang ZG, Zhu GC, Zhang C. Laparoscopic Nissen fundoplication is more effective in treating patients with GERD-related chronic cough than Stretta radiofrequency. Minerva Chir. 2014;69(3):121–7.PubMed
23.•
Zurück zum Zitat Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28(8):2323–33. doi:10.1007/s00464-014-3461-6. Long-term data on the Stretta procedure.CrossRefPubMed Noar M, Squires P, Noar E, Lee M. Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later. Surg Endosc. 2014;28(8):2323–33. doi:10.​1007/​s00464-014-3461-6. Long-term data on the Stretta procedure.CrossRefPubMed
25.
Zurück zum Zitat Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(6):1058–67.e1. doi:10.1016/j.cgh.2014.10.013.CrossRefPubMed Lipka S, Kumar A, Richter JE. No evidence for efficacy of radiofrequency ablation for treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(6):1058–67.e1. doi:10.​1016/​j.​cgh.​2014.​10.​013.CrossRefPubMed
26.
Zurück zum Zitat Håkansson B, Montgomery M, Cadiere GB, Rajan A, Bruley des Varannes S, Lerhun M, et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42(11-12):1261–70. doi:10.1111/apt.13427.CrossRefPubMed Håkansson B, Montgomery M, Cadiere GB, Rajan A, Bruley des Varannes S, Lerhun M, et al. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD. Aliment Pharmacol Ther. 2015;42(11-12):1261–70. doi:10.​1111/​apt.​13427.CrossRefPubMed
27.
Zurück zum Zitat Witteman BP, Conchillo JM, Rinsma NF, Betzel B, Peeters A, Koek GH, et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110(4):531–42. doi:10.1038/ajg.2015.28.CrossRefPubMed Witteman BP, Conchillo JM, Rinsma NF, Betzel B, Peeters A, Koek GH, et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015;110(4):531–42. doi:10.​1038/​ajg.​2015.​28.CrossRefPubMed
28.••
Zurück zum Zitat Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–333.e5. doi:10.1053/j.gastro.2014.10.009. RCT of TF in the treatment of regurgitation, an important endpoint in the management of GERD in the PPI era.CrossRefPubMed Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–333.e5. doi:10.​1053/​j.​gastro.​2014.​10.​009. RCT of TF in the treatment of regurgitation, an important endpoint in the management of GERD in the PPI era.CrossRefPubMed
29.
Zurück zum Zitat Trad KS, Simoni G, Barnes WE, Shughoury AB, Raza M, Heise JA, et al. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study. BMC Gastroenterol. 2014;14:174. doi:10.1186/1471-230X-14-174.CrossRefPubMedPubMedCentral Trad KS, Simoni G, Barnes WE, Shughoury AB, Raza M, Heise JA, et al. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study. BMC Gastroenterol. 2014;14:174. doi:10.​1186/​1471-230X-14-174.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov. 2015;22(1):26–40. doi:10.1177/1553350614526788.CrossRefPubMedPubMedCentral Trad KS, Barnes WE, Simoni G, Shughoury AB, Mavrelis PG, Raza M, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial. Surg Innov. 2015;22(1):26–40. doi:10.​1177/​1553350614526788​.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Bell RC, Barnes WE, Carter BJ, Sewell RW, Mavrelis PG, Ihde GM, et al. Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study. Am Surg. 2014;80(11):1093–105.PubMed Bell RC, Barnes WE, Carter BJ, Sewell RW, Mavrelis PG, Ihde GM, et al. Transoral incisionless fundoplication: 2-year results from the prospective multicenter U.S. study. Am Surg. 2014;80(11):1093–105.PubMed
32.
Zurück zum Zitat Wilson EB, Barnes WE, Mavrelis PG, Carter BJ, Bell RC, Sewell RW, et al. The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience. Surg Laparosc Endosc Percutan Tech. 2014;24(1):36–46. doi:10.1097/SLE.0b013e3182a2b05c.CrossRefPubMed Wilson EB, Barnes WE, Mavrelis PG, Carter BJ, Bell RC, Sewell RW, et al. The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience. Surg Laparosc Endosc Percutan Tech. 2014;24(1):36–46. doi:10.​1097/​SLE.​0b013e3182a2b05c​.CrossRefPubMed
33.•
Zurück zum Zitat Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2015;29(9):2770–80. doi:10.1007/s00464-014-4008-6. Long-term data with TF.CrossRefPubMed Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2015;29(9):2770–80. doi:10.​1007/​s00464-014-4008-6. Long-term data with TF.CrossRefPubMed
34.
35.
Zurück zum Zitat Smeets FG, Keszthelyi D, Bouvy ND, Masclee AA, Conchillo JM. Does measurement of esophagogastric junction distensibility by EndoFLIP predict therapy-responsiveness to endoluminal fundoplication in patients with gastroesophageal reflux disease? J Neurogastroenterol Motil. 2015;21(2):255–64. doi:10.5056/jnm14111.CrossRefPubMedPubMedCentral Smeets FG, Keszthelyi D, Bouvy ND, Masclee AA, Conchillo JM. Does measurement of esophagogastric junction distensibility by EndoFLIP predict therapy-responsiveness to endoluminal fundoplication in patients with gastroesophageal reflux disease? J Neurogastroenterol Motil. 2015;21(2):255–64. doi:10.​5056/​jnm14111.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Danalioglu A, Cipe G, Toydemir T, Kocaman O, Ince AT, Muslumanoglu M, et al. Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease. Dig Endosc. 2014;26(1):37–42. doi:10.1111/den.12081.CrossRefPubMed Danalioglu A, Cipe G, Toydemir T, Kocaman O, Ince AT, Muslumanoglu M, et al. Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease. Dig Endosc. 2014;26(1):37–42. doi:10.​1111/​den.​12081.CrossRefPubMed
41.
Zurück zum Zitat Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29:220–9.CrossRefPubMed Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, et al. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29:220–9.CrossRefPubMed
42.
Zurück zum Zitat Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27:346–51.PubMedPubMedCentral Inoue H, Ito H, Ikeda H, Sato C, Sato H, Phalanusitthepha C, et al. Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study. Ann Gastroenterol. 2014;27:346–51.PubMedPubMedCentral
Metadaten
Titel
Endoscopic Options for Gastroesophageal Reflux: Where Are We Now and What Does the Future Hold?
verfasst von
George Triadafilopoulos
Publikationsdatum
01.09.2016
Verlag
Springer US
Erschienen in
Current Gastroenterology Reports / Ausgabe 9/2016
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-016-0521-1

Weitere Artikel der Ausgabe 9/2016

Current Gastroenterology Reports 9/2016 Zur Ausgabe

Inflammatory Bowel Disease (S Hanauer, Section Editor)

Approach to the Patient with Mild Crohn’s Disease: a 2016 Update

Inflammatory Bowel Disease (S Hanauer, Section Editor)

Next-Generation Therapeutics for Inflammatory Bowel Disease

Nutrition and Obesity (S McClave and J Obert, Section Editors)

The Critical Care Obesity Paradox and Implications for Nutrition Support

Nutrition and Obesity (S McClave, Section Editor)

Intestinal Failure: New Definition and Clinical Implications

Stomach and Duodenum (J Pisegna and J Benhammou, Section Editors)

Laparoscopic-Assisted Percutaneous Endoscopic Gastrostomy

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.